Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.

Standard

Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer. / Wölber, Linn; Jung, S; Zu Eulenburg, Christine Gräfin; Müller, Volkmar; Schwarz, Jörg; Jänicke, Fritz; Mahner, Sven.

in: EJSO-EUR J SURG ONC, Jahrgang 36, Nr. 6, 6, 2010, S. 583-588.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{23d719845a604f66a668f62eddf02d61,
title = "Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.",
abstract = "Despite radical surgical and chemotherapeutic treatment of ovarian cancer, the majority of patients develop recurrent disease. Secondary cytoreductive surgery can result in favourable outcome in selected patients, but information regarding feasibility, safety and perioperative outcome of these often complex procedures is limited.",
author = "Linn W{\"o}lber and S Jung and {Zu Eulenburg}, {Christine Gr{\"a}fin} and Volkmar M{\"u}ller and J{\"o}rg Schwarz and Fritz J{\"a}nicke and Sven Mahner",
year = "2010",
language = "Deutsch",
volume = "36",
pages = "583--588",
journal = "EJSO-EUR J SURG ONC",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "6",

}

RIS

TY - JOUR

T1 - Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.

AU - Wölber, Linn

AU - Jung, S

AU - Zu Eulenburg, Christine Gräfin

AU - Müller, Volkmar

AU - Schwarz, Jörg

AU - Jänicke, Fritz

AU - Mahner, Sven

PY - 2010

Y1 - 2010

N2 - Despite radical surgical and chemotherapeutic treatment of ovarian cancer, the majority of patients develop recurrent disease. Secondary cytoreductive surgery can result in favourable outcome in selected patients, but information regarding feasibility, safety and perioperative outcome of these often complex procedures is limited.

AB - Despite radical surgical and chemotherapeutic treatment of ovarian cancer, the majority of patients develop recurrent disease. Secondary cytoreductive surgery can result in favourable outcome in selected patients, but information regarding feasibility, safety and perioperative outcome of these often complex procedures is limited.

M3 - SCORING: Zeitschriftenaufsatz

VL - 36

SP - 583

EP - 588

JO - EJSO-EUR J SURG ONC

JF - EJSO-EUR J SURG ONC

SN - 0748-7983

IS - 6

M1 - 6

ER -